Welcome, Guest. Please login or register.
October 13, 2024, 07:07:58 pm

Login with username, password and session length


Members
  • Total Members: 37920
  • Latest: Ronet22
Stats
  • Total Posts: 775010
  • Total Topics: 66546
  • Online Today: 890
  • Online Ever: 5484
  • (June 18, 2021, 11:15:29 pm)
Users Online
Users: 1
Guests: 865
Total: 866

Welcome


Welcome to the POZ Community Forums, a round-the-clock discussion area for people with HIV/AIDS, their friends/family/caregivers, and others concerned about HIV/AIDS.  Click on the links below to browse our various forums; scroll down for a glance at the most recent posts; or join in the conversation yourself by registering on the left side of this page.

Privacy Warning:  Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If you are HIV positive and disclose this in our forums, then it is almost the same thing as telling the whole world (or at least the World Wide Web). If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.

  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.

  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.

  • Forums members must behave at all times with respect and honesty. Posting guidelines, including time-out and banning policies, have been established by the moderators of these forums. Click here for “Do I Have HIV?” posting guidelines. Click here for posting guidelines pertaining to all other POZ community forums.

  • We ask all forums members to provide references for health/medical/scientific information they provide, when it is not a personal experience being discussed. Please provide hyperlinks with full URLs or full citations of published works not available via the Internet. Additionally, all forums members must post information which are true and correct to their knowledge.

  • Product advertisement—including links; banners; editorial content; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from POZ.

To change forums navigation language settings, click here (members only), Register now

Para cambiar sus preferencias de los foros en español, haz clic aquí (sólo miembros), Regístrate ahora

Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Shanghai Public Health Clinical Center Completed the First Patient Dosing  (Read 5723 times)

0 Members and 1 Guest are viewing this topic.

Offline Da2020

  • Member
  • Posts: 41
https://finance.yahoo.com/news/shanghai-public-health-clinical-center-001000547.html

HANGZHOU and SHAOXING, China, July 4, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces that the clinical study of PD-L1 antibody ASC22 in combination with Chidamide for functional cure of human immunodeficiency virus (HIV) infection, which was initiated by Shanghai Public Health Clinical Center, has completed the first patient dosing recently.

Previously, Ascletis announced the completion of the first patient dosing in the Phase II clinical trial of ASC22 as a monotherapy based on anti-retroviral therapy (ART) for immune restoration/ functional cure of human immunodeficiency virus 1 (HIV-1) infection

Offline nethan1621

  • Member
  • Posts: 48
Well done china.. we need to end the monopoly of HIV business and increase more competitors in the field.. 😁😁 now we can analyze that  treating HIV is cheaper than Treating Diabetes with Insulin. India Biktarvy is just 40$ per month and other test are Free . Meanwhile another part of the world selling same drug for 5400$ .. what a scam.. business should be fair user policy guys.. we need more competitors … 🤓

Offline Jim Allen

  • Administrator
  • Member
  • Posts: 23,030
  • Threads: @jim16309
    • Social Media: Threads
https://finance.yahoo.com/news/shanghai-public-health-clinical-center-001000547.html

HANGZHOU and SHAOXING, China, July 4, 2022 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") today announces that the clinical study of PD-L1 antibody ASC22 in combination with Chidamide for functional cure of human immunodeficiency virus (HIV) infection, which was initiated by Shanghai Public Health Clinical Center, has completed the first patient dosing recently.

Previously, Ascletis announced the completion of the first patient dosing in the Phase II clinical trial of ASC22 as a monotherapy based on anti-retroviral therapy (ART) for immune restoration/ functional cure of human immunodeficiency virus 1 (HIV-1) infection

Interesting read but a very early stage. Would like to see more data from them and have been unable to find anything peer reviewed yet.
« Last Edit: July 07, 2022, 04:22:33 pm by Jim Allen »
HIV 101 - Everything you need to know
HIV 101
Read more about Testing here:
HIV Testing
Read about Treatment-as-Prevention (TasP) here:
HIV TasP
You can read about HIV prevention here:
HIV prevention
Read about PEP and PrEP here
PEP and PrEP

My Instagram
Threads

Offline Jim Allen

  • Administrator
  • Member
  • Posts: 23,030
  • Threads: @jim16309
    • Social Media: Threads
Well done china.. we need to end the monopoly of HIV business and increase more competitors in the field.. 😁😁 now we can analyze that  treating HIV is cheaper than Treating Diabetes with Insulin. India Biktarvy is just 40$ per month and other test are Free . Meanwhile another part of the world selling same drug for 5400$ .. what a scam.. business should be fair user policy guys.. we need more competitors … 🤓

Seems like they wanna stop unsafe activity based on previous published 99% effectiveness used to promote prep and now its time-to decrease unsafe activity after achieving considerable amount of prep users worldwide… pretty clear what they did.

Look stop it with this, half of this is plain rubbish and the other half seems to be an issue with capitalism, by all means, open a thread if you like on the topic of capitalism but stop responding to threads in the research section with this. 
HIV 101 - Everything you need to know
HIV 101
Read more about Testing here:
HIV Testing
Read about Treatment-as-Prevention (TasP) here:
HIV TasP
You can read about HIV prevention here:
HIV prevention
Read about PEP and PrEP here
PEP and PrEP

My Instagram
Threads

Offline Da2020

  • Member
  • Posts: 41
Interesting read but a very early stage. Would like to see more data from them and have been unable to find anything peer reviewed yet.

Me neither. Did a bunch of research still couldn’t find anything.( prolly a china thing)

 


Terms of Membership for these forums
 

© 2024 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.